Diagnostics Development Co-op (July '26 Start)
Nanopath
About this role
Nanopath is a diagnostics company developing an in vitro platform to revolutionize disease diagnosis, aiming to bring molecular testing closer to patients and improve health outcomes. The company emphasizes health equity, sustainability, and innovation in medtech.
Skills
Qualifications
About Nanopath
nanopath.comNanopath is a diagnostics company focused on women's health that develops advanced molecular testing technologies. The company says it has achieved deep technological breakthroughs—using nano‑enabled approaches—that have the potential to change the molecular diagnostic paradigm. Nanopath aims to translate those innovations into diagnostic platforms and assays that improve sensitivity, speed, and clinical decision‑making in women’s healthcare.
Recent company news
PR NewswireNanopath Granted FDA Breakthrough Device Designation for Its Molecular Diagnostic Platform for Urinary Tract Infections
Nov 18, 2025
Clinical Lab ProductsFDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform
Nov 18, 2025
Medical Product OutsourcingNanopath Expands Leadership Team
Nov 12, 2025
Modern HealthcareFDA clearances: Dexcom, GE HealthCare, Zimmer Biomet, BrainsWay
Nov 20, 2025
PR NewswireNanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
May 21, 2024
About Nanopath
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Nanopath .